Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-10-011225)

Filing Details

Accession Number:: 0001179110-10-011225
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-07-01 13:00:00
Reporting Period:: 2010-06-30

Filing Date:: 2010-07-01
Accepted Time:: 2010-07-01 19:42:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1289884	B Steven Ketchum	C/O Sunesis Pharmaceuticals, Inc. 395 Oyster Point Blvd., Suite 400 South San Francisco CA 94080	Sr. Vice President, R & D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-06-30	238,243	$0.28	240,595	No	4	P	Direct
Common Stock	Acquisiton	2010-06-30	99,940	$0.00	340,535	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2010-06-30	9,994	$0.00	99,940	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The Series A Preferred Stock automatically converted into common stock in accordance with the terms of the applicabale Certificate of Designation of the Issuer on a 1-for-10 basis and had no expiration date.